Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three separate medications: paracetamol (acetaminophen), tramadol, and ondansetron. Paracetamol and tramadol together form a fixed-dose combination analgesic (often marketed as Ultracet) for moderate to severe pain, while ondansetron is a 5-HT3 receptor antagonist used to manage nausea and vomiting. This three-drug combination may be used in clinical practice, particularly for post-operative pain management where pain control and prevention of nausea/vomiting are both important. ## Medication Components **Paracetamol (Acetaminophen)**: An analgesic with unknown exact mechanism but believed to work through central and peripheral effects. **Tramadol**: A centrally acting synthetic opioid analgesic and serotonin-norepinephrine reuptake inhibitor (SNRI) that has about 1/10th the potency of morphine. It works through multiple mechanisms including μ-opioid receptor agonism and effects on serotonin and norepinephrine. **Ondansetron**: A serotonin (5-HT3) receptor antagonist primarily used to treat nausea and vomiting. ## Interactions and Clinical Considerations There are potential interactions between these medications that clinicians should be aware of: 1. **Tramadol and Ondansetron Interaction**: Some studies suggest there may be a pharmacodynamic interaction between tramadol and ondansetron. There are conflicting findings about whether ondansetron reduces the analgesic efficacy of tramadol[2]. Some research indicates that ondansetron might block tramadol's effects, potentially increasing tramadol consumption in patients[2], while other studies found no significant change in tramadol consumption when co-administered with ondansetron[2]. 2. **Paracetamol and Ondansetron Interaction**: Interestingly, one study found that co-administration of paracetamol and ondansetron actually increased the analgesic effect of paracetamol, contrary to earlier findings with other 5-HT3 antagonists[5]. This study recommended the co-administration of paracetamol and ondansetron for effective postoperative pain management[5]. 3. **Combined Use in Clinical Practice**: The tramadol-paracetamol combination (Ultracet) is indicated for the symptomatic treatment of moderate to severe pain[3]. Ondansetron may be prescribed alongside this combination to manage potential nausea and vomiting, which are common side effects of tramadol. The combination of these three medications requires careful consideration of potential interactions and side effects. Healthcare providers should monitor patients closely when these medications are used together, particularly for efficacy of pain relief and any adverse effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on paracetamol + tramadol + ondansetron.